Non-invasive TRanscutaneous Cervical Vagus Nerve Stimulation as a Treatment for Acute Stroke; Safety and Feasibility Study

NACompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

May 10, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

April 1, 2021

Conditions
Stroke, AcuteStroke, IschemicStrokeStroke, Hemorrhagic
Interventions
DEVICE

Gammacore device

Transcutaneous stimulation of vagus nerve with the device positioned below the mandibular angle, medial to the sternocleidomastoid muscle and lateral to the larynx.

DEVICE

Gammacore sham device

Sham device which does not deliver electrical stimulation, but instead, produces a buzzing sound will be placed along the lateral border of the sternocleidomastoid muscle in order to avoid mechanical stimulation of the vagus nerve in the carotid triangle.

Trial Locations (8)

Unknown

Ankara University Faculty of Medicine, Ankara

Gazi University Faculty Of Medicine, Ankara

Hacettepe University Faculty of Medicine, Ankara

Akdeniz University, Antalya

Eskişehir Osmangazi Faculty of Medicine, Eskişehir

Necmettin Erbakan University, Konya

Selcuk University, Konya

Ondokuz Mayıs University Faculty of Medicine, Samsun

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Turkish Neurological Society

UNKNOWN

collaborator

ElectroCore INC

INDUSTRY

lead

Turkish Stroke Research and Clinical Trials Network

NETWORK

NCT03733431 - Non-invasive TRanscutaneous Cervical Vagus Nerve Stimulation as a Treatment for Acute Stroke; Safety and Feasibility Study | Biotech Hunter | Biotech Hunter